NCT00563784 2019-11-20TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)M.D. Anderson Cancer CenterPhase 2 Completed68 enrolled 11 charts